Article
Genetic Testing for Malignant Hyperthermia Susceptibility – Threading the Needle in the Haystack
2025-08-25
Abstract excerpt
Malignant hyperthermia (MH) is a rare pharmacogenetic disorder triggered by volatile anesthetics and succinylcholine, most often linked to pathogenic variants in RYR1, CACNA1S, and STAC3. The advent of next-generation sequencing (NGS) has transformed MH diagnostics, offering new opportunities for perioperative risk assessment as caffeine-halothane contracture testing declines. However, challenges remain, including...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 2219e170-13c0-51fe-be5c-9532654e6dcb
- DOI
- 10.20944/preprints202508.1695.v1
